Varenicline adjunctive treatment in schizophrenia.
Phase of Trial: Phase IV
Latest Information Update: 13 Dec 2017
At a glance
- Drugs Varenicline (Primary)
- Indications Psychotic disorders; Schizoaffective disorder; Schizophrenia
- Focus Biomarker; Therapeutic Use
- 19 Mar 2012 Planned end date changed from 1 Jan 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 17 Aug 2011 Status changed from active, no longer recruiting to completed.
- 07 Sep 2010 Planned end date changed from 1 Jun 2010 to 1 Jan 2011 as reported by ClinicalTrials.gov.